» Articles » PMID: 36358629

PARP10 Mediates Mono-ADP-Ribosylation of Aurora-A Regulating G2/M Transition of the Cell Cycle

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Nov 11
PMID 36358629
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular mono-ADP-ribosyltransferases (mono-ARTs) catalyze the covalent attachment of a single ADP-ribose molecule to protein substrates, thus regulating their functions. PARP10 is a soluble mono-ART involved in the modulation of intracellular signaling, metabolism and apoptosis. PARP10 also participates in the regulation of the G1- and S-phase of the cell cycle. However, the role of this enzyme in G2/M progression is not defined. In this study, we found that genetic ablation, protein depletion and pharmacological inhibition of PARP10 cause a delay in the G2/M transition of the cell cycle. Moreover, we found that the mitotic kinase Aurora-A, a previously identified PARP10 substrate, is actively mono-ADP-ribosylated (MARylated) during G2/M transition in a PARP10-dependent manner. Notably, we showed that PARP10-mediated MARylation of Aurora-A enhances the activity of the kinase in vitro. Consistent with an impairment in the endogenous activity of Aurora-A, cells lacking PARP10 show a decreased localization of the kinase on the centrosomes and mitotic spindle during G2/M progression. Taken together, our data provide the first evidence of a direct role played by PARP10 in the progression of G2 and mitosis, an event that is strictly correlated to the endogenous MARylation of Aurora-A, thus proposing a novel mechanism for the modulation of Aurora-A kinase activity.

Citing Articles

PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.

Morone B, Grimaldi G Expert Rev Mol Med. 2024; 26:e17.

PMID: 39189367 PMC: 11440612. DOI: 10.1017/erm.2024.13.


Pathological and physiological roles of ADP-ribosylation: established functions and new insights.

Feijs-Zaja K, Ikenga N, Zaja R Biol Chem. 2024; .

PMID: 39066732 DOI: 10.1515/hsz-2024-0057.


Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms.

Wu H, Lu A, Yuan J, Yu Y, Lv C, Lu J Cell Death Discov. 2024; 10(1):226.

PMID: 38734665 PMC: 11088682. DOI: 10.1038/s41420-024-01994-5.


ADP-ribosylation from molecular mechanisms to therapeutic implications.

Suskiewicz M, Prokhorova E, Rack J, Ahel I Cell. 2023; 186(21):4475-4495.

PMID: 37832523 PMC: 10789625. DOI: 10.1016/j.cell.2023.08.030.


Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs.

Nizi M, Sarnari C, Tabarrini O Molecules. 2023; 28(15).

PMID: 37570820 PMC: 10420676. DOI: 10.3390/molecules28155849.


References
1.
Wang Z, Grosskurth S, Cheung T, Petteruti P, Zhang J, Wang X . Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer. Cancer Res. 2018; 78(23):6691-6702. DOI: 10.1158/0008-5472.CAN-18-1362. View

2.
Wang G, Jiang Q, Zhang C . The role of mitotic kinases in coupling the centrosome cycle with the assembly of the mitotic spindle. J Cell Sci. 2014; 127(Pt 19):4111-22. DOI: 10.1242/jcs.151753. View

3.
Iwata H, Goettsch C, Sharma A, Ricchiuto P, Goh W, Halu A . PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation. Nat Commun. 2016; 7:12849. PMC: 5095532. DOI: 10.1038/ncomms12849. View

4.
Barbarulo A, Iansante V, Chaidos A, Naresh K, Rahemtulla A, Franzoso G . Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma. Oncogene. 2012; 32(36):4231-42. DOI: 10.1038/onc.2012.448. View

5.
Hutterer A, Berdnik D, Wirtz-Peitz F, Zigman M, Schleiffer A, Knoblich J . Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev Cell. 2006; 11(2):147-57. DOI: 10.1016/j.devcel.2006.06.002. View